Towards Healthcare
HIV Clinical Trials Market to Reach USD 2.54 Bn by 2034

HIV Clinical Trials Market Boosted by Advancing Vaccine Trials

Projections indicate that, the global HIV clinical trials market will increase from USD 1.27 billion in 2024 to USD 2.54 billion by 2034, experiencing a CAGR of 7.17% over the next 10 years. The HIV clinical trials market is expanding due to growing research and development, as well as rising HIV vaccine development. North America led the market due to the presence of a well-developed research and development infrastructure.

Content

  • Last Updated: 10 September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The HIV clinical trials market in 2025 is valued at USD 1.36 billion and is projected to climb to USD 2.54 billion by 2034, with a CAGR of 7.17% over the forecast period.

North America is currently leading the HIV clinical trials market due to the presence of advanced research and development infrastructure.

The HIV clinical trials market includes four segments such as by trial phase, by therapeutic modality/intervention type, by sponsor type, and by region.

HIV clinical trials focus on all clinical research activities conducted to discover, develop, evaluate, and validate therapies, prevention strategies, vaccines, diagnostics/biomarkers, and potential cures for Human Immunodeficiency Virus (HIV).

The growing demand for preventive or curative options drives the HIV clinical trials market growth.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions